SAB Biotherapeutics Return on Net Operating Assets Analysis

SAB Biotherapeutics, Inc. (SABS)

3.98 -0.02 (-0.50%) USD | NASDAQ | Jan 16, 16:00

4.00 +0.02 (+0.50%) After-Hours: 20:00

View Return on Net Operating Assets for SABS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

CEL-SCI Corp.	Upgrade
AIM ImmunoTech, Inc.	Upgrade
IGC Pharma, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade
Protalix Biotherapeutics, Inc.	Upgrade